New-onset chilblains in close temporal association to mRNA-1273 vaccination
Connie Kha, Aleksandr Itkin
Abstract
Chilblains are one of the earliest and most commonly described cutaneous manifestations of COVID-19;1 however, more recent data have failed to suggest an association. As widespread vaccinations are underway, reports of delayed-type hypersensitivity reactions in recipients of the mRNA-1273 vaccine have been brought to attention. Here, we present a case of biopsy-confirmed chilblains developing shortly after vaccination in an asymptomatic healthcare worker, who was not tested for SARS-CoV-2.
Topics & Concepts
MedicineVaccinationAsymptomaticDermatologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakImmunologyVirologyPathologyDiseaseOutbreakInfectious disease (medical specialty)Dermatological and COVID-19 studiesStreptococcal Infections and TreatmentsParvovirus B19 Infection Studies